Estimated antiretroviral therapy coverage among people living with HIV in EMR
EMR: Estimated antiretroviral therapy coverage among people living with HIV was 31.0% in 2025. ◆ Volatile
Estimated antiretroviral therapy coverage among people living with HIV in EMR, 2000–2025
Source: World Health Organization, Global Health Observatory.
Analysis
In 2025, estimated antiretroviral therapy coverage among people living with hiv in EMR stood at 31.0%. That is the highest value across all 26 years on record.
That represents a change of up 3.3% on the previous year and up 121.4% over ten years.
Over the whole period, estimated antiretroviral therapy coverage among people living with hiv in EMR peaked at 31.0% in 2025 and was at its lowest, 2.0%, in 2000.
The series is highly variable year to year, so single readings are best treated with caution.
Estimated antiretroviral therapy coverage among people living with HIV in EMR, year by year
| Year | Value | Change |
|---|---|---|
| 2000 | 2.0% | — |
| 2001 | 2.0% | +0.0% |
| 2002 | 2.0% | +0.0% |
| 2003 | 3.0% | +50.0% |
| 2004 | 3.0% | +0.0% |
| 2005 | 4.0% | +33.3% |
| 2006 | 4.0% | +0.0% |
| 2007 | 5.0% | +25.0% |
| 2008 | 6.0% | +20.0% |
| 2009 | 7.0% | +16.7% |
| 2010 | 8.0% | +14.3% |
| 2011 | 8.0% | +0.0% |
| 2012 | 10.0% | +25.0% |
| 2013 | 11.0% | +10.0% |
| 2014 | 12.0% | +9.1% |
| 2015 | 14.0% | +16.7% |
| 2016 | 16.0% | +14.3% |
| 2017 | 19.0% | +18.8% |
| 2018 | 21.0% | +10.5% |
| 2019 | 24.0% | +14.3% |
| 2020 | 24.0% | +0.0% |
| 2021 | 24.0% | +0.0% |
| 2022 | 26.0% | +8.3% |
| 2023 | 28.0% | +7.7% |
| 2024 | 30.0% | +7.1% |
| 2025 | 31.0% | +3.3% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 3.8% | 2.0% | 7.0% | 10 |
| 2010s | 14.3% | 8.0% | 24.0% | 10 |
| 2020s | 27.2% | 24.0% | 31.0% | 6 |
Countries ranked near EMR
More health data for EMR
- Mortality rate among children ages 5 to 9 years 3.61 (2024)
- Population with primary reliance on polluting fuels and technologies 172.72 (2023)
- Population with primary reliance on fuels and technologies for 153.85 (2023)
- Proportion of population with primary reliance on fuels and 41.0% (2023)
- Prevalence of diabetes, crude 20.38 (2022)
- Diphtheria tetanus toxoid and pertussis first-dose (DTP1) 88.0% (2025)
- Measles-containing-vaccine first-dose (MCV1) immunization coverage 81.0% (2025)
- New HIV infections 0.1 (2025)
- BCG immunization coverage among 1-year-olds (%) 88.0% (2025)
- Mean total cholesterol, crude 4.3 (2018)
Frequently asked questions
- What is estimated antiretroviral therapy coverage among people living with hiv in EMR?
- Estimated antiretroviral therapy coverage among people living with hiv in EMR was 31.0% in 2025, according to World Health Organization, Global Health Observatory.
- What is the highest estimated antiretroviral therapy coverage among people living with hiv recorded in EMR?
- The highest recorded value was 31.0% in 2025.
- What is the lowest estimated antiretroviral therapy coverage among people living with hiv recorded in EMR?
- The lowest recorded value was 2.0% in 2000.
- How does EMR rank for estimated antiretroviral therapy coverage among people living with hiv?
- EMR ranks 10th out of 13 groups with data for 2025.
- Is estimated antiretroviral therapy coverage among people living with hiv rising or falling in EMR?
- Over the last ten years it is up 121.4%. The long-run trend across the full record is volatile.
- Where does this EMR data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Estimated antiretroviral therapy coverage among people living with HIV (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 26 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).